Resection of ciliary body tumours wins EURETINA Video Awards

The intricacies of vitreoretinal surgery in all its glorious complexity was showcased in the 2014
EURETINA Video Awards, with the very high standard of entries this year praised by Francesco
Bandello, president of EURETINA.
First prize went to Maria Isabel Relimpio Lopez, of Spain for her video entitled “Partial Lamellar
Sclerouvectomy of two ciliary body tumours: Two surgical techniques.” Joint second prize awards
went to Peykan Turkcuoglu from Turkey for “Suprachoroidal haemorrhage during pars plana
vitrectomy in a previously vitrectomised eye” and Shokufeh Tavassoli from the UK for “Top ten
intravitreal injection tips”. Third prize was given to Avnindra Gupta from India for “Mystery Unfolds”,
which explored surgical techniques for dealing with macular folds.
Dr Lopez’s prize-winning entry gave an elegant example of partial lamellar sclerouvectomy to deal
with the rare incidence of ciliary body tumours in two patients. This surgical procedure is designed to
remove the tumour and leave intact the outer sclera and sensory retina.
In the video, Dr Lopez noted that malignant melanoma is the most common primary tumour in adults,
with management and surgical strategy depending on the size and extent of the tumour.
In the first case highlighted in the video, the surgeon used trans-illumination to mark the borders of
the tumour before performing a series of sclerotomies away from the tumour site. Since the tumour in
this patient did not affect the sclera, a partial-thickness scleral hinge was made. Cataract surgery was
then performed without IOL implantation to avoid complications during the resection. The patient
was anaesthetised using hypotensive anaesthesia, in which diastolic pressure was kept between 2
mmHg to 4 mmHg to minimise bleeding. The tumour was dissected using scissors, and diathermy was
used to coagulate the tissue.
Technically challenging
After the resection was complete, a complete vitrectomy was performed with additional prophylactic
endolaser applied to the fundus periphery. Any remaining tumour cells were destroyed using
brachytherapy at the end of the surgery. The intraocular lens was injected three months later and
improved the patient’s visual acuity to 0.3. Although technically challenging, the video demonstrated
that partial lamellar sclerouvectomy can be effective in removing some malignant ciliary body
tumours and maintaining good visual outcomes in such rare cases.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.